Sign In
to Vote &
Create Storyboards.
 
Janssen has announced the launch of INVOKANA® (canagliflozin) in the UK, a new Type 2 diabetes treatment shown to reduce blood sugar levels in people for whom diet and lifestyle measures or treatment with other blood sugar-lowering medicines, do not provide adequate control.1In parallel with today's launch, canagliflozin has also received a preliminary positive recommendation from the National Institute for Health and Care Excellence (NICE), as a treatment option for adults with Type 2 diabetes...
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard